Interaction with Sajal Kapoor and Aditya Khemka have mentioned that Sequent seems to be giving not satisfactory answers on how they have brand power. Also, there were comments that, unlike earlier times, Sequent is not the only big listed player in the animal pharma space with other players entering the formulation and API space.
Could experts weigh in on the barrier to entry for others to disrupt Sequent completely?
| Subscribe To Our Free Newsletter |
